Skip to search.
 BSE Up 0.19% NSE Up 0.19%
Streaming
Ticker Tape: On

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM

1.79 22 May 1:30AM

Add to Portfolio
Prev Close:1.79
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.88
Beta:1.53
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.49 - 6.33
Volume:0
Avg Vol (3m):2,048,170
Market Cap:148.71M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOP 0.00%148.71M
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 0.05%11.77B
SUNPHARMA.NSUp 3.23%1.04T
GILD.MXUp 2.12%1.06T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):185.89
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.91
Quarterly EPS Est (Jun-13) :-0.24
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of new cancer therapies. Its lead candidate, Palifosfamide (ZIO-201), a DNA alkylating agent, is under Phase III clinical trial for the treatmen... View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback